Journal of Periodontology

Volume 81, Issue 4 p. 479-484

News, View, and Review

Osseointegration of Dental Implants in Patients Undergoing Bisphosphonate Treatment: A Literature Review

Fawad Javed,

Corresponding Author

Fawad Javed

[email protected]

Department of Dental Medicine, Division of Research, Karolinska Institute, Huddinge, Sweden.

Correspondence: Dr. Fawad Javed, Division of Research, Department of Dental Medicine, Karolinska Institute, Huddinge, Sweden. e-mail: [email protected].Search for more papers by this author

Khalid Almas,

Khalid Almas

Division of Periodontology, School of Dental Medicine, University of Connecticut, Farmington, CT.

Search for more papers by this author

Fawad Javed,

Corresponding Author

Fawad Javed

[email protected]

Department of Dental Medicine, Division of Research, Karolinska Institute, Huddinge, Sweden.

Correspondence: Dr. Fawad Javed, Division of Research, Department of Dental Medicine, Karolinska Institute, Huddinge, Sweden. e-mail: [email protected].Search for more papers by this author

Khalid Almas,

Khalid Almas

Division of Periodontology, School of Dental Medicine, University of Connecticut, Farmington, CT.

Search for more papers by this author

First published: 01 April 2010

https://doi.org/10.1902/jop.2009.090587

Citations: 68

Read the full text

About

PDF

Tools

Share a link

Email
Facebook
Twitter
LinkedIn
Reddit
Wechat

Abstract

Background: Bisphosphonates (BPs) are an important group of drugs used for the treatment of metabolic and oncologic pathologies involving the skeletal system. Osteonecrosis of the jaw (ONJ) is a complication observed in patients using oral or intravenous (IV) BPs. It was suggested that all patients undergoing BP therapy who are expected to receive dental implants should be informed of the possible risks of development of ONJ. The aim of this literature review is to assess the osseointegration of dental implants in patients undergoing BP therapy.

Methods: The MEDLINE–PubMed databases of The National Library of Medicine, National Institutes of Health, Bethesda, Maryland, were searched for articles addressing the focused question: Can dental implants osseointegrate and remain functionally stable in patients undergoing oral and IV BP therapy? Databases were searched from 1995 up to and including February 2010 using the following terms in different combinations: bisphosphonate, dental implant, immediate-loading, implant survival rate, intravenous, oral, osseointegration, and osteonecrosis.

Results: The initial search yielded 89 articles. Scrutiny of the titles and abstracts reduced the number of articles to 12 (seven case reports and five retrospective studies). In 10 studies, the patients were using oral BPs, and in two studies, patients were using IV BPs. Six case reports showed that the placement of implants in patients using BPs could yield a successful osseointegration and function. Four retrospective studies demonstrated that BPs did not have a negative influence on implant success. Two studies showed a negative impact of BPs on implant success.

Conclusion: Dental implants can osseointegrate and remain functionally stable in patients using BPs.

REFERENCES

1Green JR. Bisphosphonates: Preclinical review. Oncologist 2004; 9(Suppl. 4): 3–13.
10.1634/theoncologist.9-90004-3
CASPubMedWeb of Science®Google Scholar
2Frith JC, Mönkkönen J, Blackburn GM, Russell RG, Rogers MJ. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosire 5′-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 1997; 12: 1358–1367.
10.1359/jbmr.1997.12.9.1358
CASPubMedWeb of Science®Google Scholar
3Tenenbaum HC, Shelemay A, Girard B, Zohar R, Fritz PC. Bisphosphonates and periodontics: Potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses. J Periodontol 2002; 73: 813–822.
10.1902/jop.2002.73.7.813
CASPubMedWeb of Science®Google Scholar
4Fleisch H. Bisphosphonates: Mechanisms of action. Endocr Rev 1998; 19: 80–100.
10.1210/edrv.19.1.0325
CASPubMedWeb of Science®Google Scholar
5Reszka AA, Rodan GA. Mechanism of action of bisphosphonates. Curr Osteoporos Rep 2003; 1: 45–52.
10.1007/s11914-003-0008-5
PubMedGoogle Scholar
6Otomo-Corgel J. Implants and oral bisphosphonates: Risky business? J Periodontol 2007; 78: 373–376.
10.1902/jop.2007.073001
CASPubMedWeb of Science®Google Scholar
7Vahtsevanos K, Kyrgidis A, Verrou E, et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 2009; 27: 5356–5362.
10.1200/JCO.2009.21.9584
CASPubMedWeb of Science®Google Scholar
8Bilezikian JP. Osteonecrosis of the jaw – Do bisphosphonates pose a risk? N Engl J Med 2006; 355: 2278–2281.
10.1056/NEJMp068157
CASPubMedWeb of Science®Google Scholar
9Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005; 63: 1567–1575.
10.1016/j.joms.2005.07.010
PubMedWeb of Science®Google Scholar
10 Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007; 65: 369–376.
10.1016/j.joms.2006.11.003
PubMedWeb of Science®Google Scholar
11Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2007; 65: 415–423.
10.1016/j.joms.2006.10.061
PubMedWeb of Science®Google Scholar
12 American Dental Association Council for Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: Expert panel recommendations. J Am Dent Assoc 2006; 137: 1144–1150.
10.14219/jada.archive.2006.0355
PubMedGoogle Scholar
13Hewitt C, Farah CS. Bisphosphonate-related osteonecrosis of the jaws: A comprehensive review. J Oral Pathol Med 2007; 36: 319–328.
10.1111/j.1600-0714.2007.00540.x
CASPubMedWeb of Science®Google Scholar
14Javed F, Romanos GE. Impact of diabetes mellitus and glycemic control on the osseointegration of dental implants. A systematic literature review. J Periodontol 2009; 80: 1719–1730.
10.1902/jop.2009.090283
PubMedWeb of Science®Google Scholar
15Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: Literature review and a case report. J Periodontol 2007; 78: 584–594.
10.1902/jop.2007.060239
CASPubMedWeb of Science®Google Scholar
16Becker W, Hujoel PP, Becker BE, Willingham H. Osteoporosis and implant failure: An exploratory case-control study. J Periodontol 2000; 71: 625–631.
10.1902/jop.2000.71.4.625
CASPubMedWeb of Science®Google Scholar
17Starck WJ, Epker BN. Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: A case report. Int J Oral Maxillofac Implants 1995; 10: 74–78.

CASPubMedGoogle Scholar
18Goss A, Bartold M, Sambrook P, Hawker P. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series. J Oral Maxillofac Surg 2010; 68: 337–343.
10.1016/j.joms.2009.09.037
PubMedWeb of Science®Google Scholar
19Sambrook P, Olver I, Goss A. Bisphosphonates and osteonecrosis of the jaw. Aust Fam Physician 2006; 35: 801–803.

PubMedGoogle Scholar
20Pirih FQ, Zablotsky M, Cordell K, McCauley LK. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy. J Mich Dent Assoc 2009; 91: 38–43.

PubMedGoogle Scholar
21Torres J, Tamimi F, Garcia I, et al. Dental implants in a patient with Paget disease under bisphosphonate treatment: A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: 387–392.
10.1016/j.tripleo.2008.11.024
PubMedWeb of Science®Google Scholar
22Kasai T, Pogrel MA, Hossaini M. The prognosis for dental implants placed in patients taking oral bisphosphonates. J Calif Dent Assoc 2009; 37: 39–42.

PubMedGoogle Scholar
23Shirota T, Nakamura A, Matsui Y, Hatori M, Nakamura M, Shintani S. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: Report of a case. Clin Oral Implants Res 2009; 20: 1402–1408.
10.1111/j.1600-0501.2009.01801.x
CASPubMedWeb of Science®Google Scholar
24Bell BM, Bell RE. Oral bisphosphonates and dental implants: A retrospective study. J Oral Maxillofac Surg 2008; 66: 1022–1024.
10.1016/j.joms.2007.12.040
PubMedWeb of Science®Google Scholar
25Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: A review of 115 cases. J Oral Maxillofac Surg 2008; 66: 223–230.
10.1016/j.joms.2007.09.019
PubMedWeb of Science®Google Scholar
26Ferrari S, Bianchi B, Savi A, et al. Fibula free flap with endosseous implants for reconstructing a resected mandible in bisphosphonate osteonecrosis. J Oral Maxillofac Surg 2008; 66: 999–1003.
10.1016/j.joms.2007.06.631
PubMedWeb of Science®Google Scholar
27Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: Postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol 2007; 78: 1664–1669.
10.1902/jop.2007.060514
CASPubMedWeb of Science®Google Scholar
28Brooks JK, Gilson AJ, Sindler AJ, Ashman SG, Schwartz KG, Nikitakis NG. Osteonecrosis of the jaws associated with use of risedronate: Report of 2 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 780–786.
10.1016/j.tripleo.2006.10.010
PubMedWeb of Science®Google Scholar
29Jeffcoat MK. Safety of oral bisphosphonates: Controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006; 21: 349–353.

PubMedWeb of Science®Google Scholar
30Melo MD, Obeid G. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. J Can Dent Assoc 2005; 71: 111–113.

PubMedGoogle Scholar
31Estilo CL, Van Poznak CH, Wiliams T, et al. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist 2008; 13: 911–920.
10.1634/theoncologist.2008-0091
PubMedWeb of Science®Google Scholar
32Reginster JY. Treatment of bone in elderly subjects: Calcium, vitamin D, fluor, bisphosphonates, calcitonin. Horm Res 1995; 43: 83–88.
10.1159/000184243
CASPubMedWeb of Science®Google Scholar
33McClung MR. Bisphosphonates. Endocrinol Metab Clin North Am 2003; 32: 253–271.
10.1016/S0889-8529(02)00079-8
CASPubMedWeb of Science®Google Scholar
34Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007; 65: 2397–2410.
10.1016/j.joms.2007.08.003
PubMedWeb of Science®Google Scholar
35Crawford BS, McNulty RM, Kraut EH, Turowski RC. Extended use of intravenous bisphosphonate therapy for the prevention of skeletal complications in patients with cancer. Cancer Invest 2009; 27: 984–988.
10.3109/07357900902783203
CASPubMedWeb of Science®Google Scholar

Citing Literature

Volume81, Issue4

April 2010

Pages 479-484

Osseointegration of Dental Implants in Patients Undergoing Bisphosphonate Treatment: A Literature Review

Abstract

REFERENCES

Citing Literature

References

Information

RESOURCES

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Osseointegration of Dental Implants in Patients Undergoing Bisphosphonate Treatment: A Literature Review

Abstract

REFERENCES

Citing Literature

References

Related

Information

RESOURCES